Contact

All Stories

  1. Targeting Human Protein Kinase CK2 by a Library of Indeno[1,2‐ b ]Indoles: Contribution of Thermal Shift Assay to Pre‐Screening and Co‐Crystallization to Post‐Screening

    Article • Archiv der Pharmazie, August 2026, Wiley

    Professor Marc Le Borgne

  2. Identification of an N-methylpyrazole derivative as a selective inhibitor of breast cancer resistance protein (BCRP/ABCG2)

    Article • Archives of Biochemistry and Biophysics, May 2026, Elsevier

    Professor Marc Le Borgne

  3. Comparative Evaluation of Solubilization Strategies for an ABCG2 Transporter Inhibitor

    Article • De Remediis, February 2026, University of Debrecen/ Debreceni Egyetem

    Professor Marc Le Borgne

  4. Synthesis of Indeno[1,2-b]indole-9,10-diones: Toward a One-Pot, Two-Step Reaction

    Article • Synthesis, January 2026, Thieme Publishing Group

    Professor Marc Le Borgne

  5. Crystallographic Fragment Screening with CK2α’, an Isoform of Human Protein Kinase CK2 Catalytic Subunit, and Its Use to Obtain a CK2α’/Heparin Complex Structure

    Article • Kinases and Phosphatases, January 2026, MDPI AG

    Professor Marc Le Borgne

  6. Functionalized nitrogen- and chalcogen-containing heterocyclic compounds as aromatase inhibitors: Design, synthesis and biological evaluation

    Article • European Journal of Medicinal Chemistry, January 2026, Elsevier

    Professor Marc Le Borgne

  7. Formulation and Evaluation of Alginate Microcapsules Containing an Uncompetitive Nanomolar Dimeric Indenoindole Inhibitor of the Human Breast Cancer Resistance Pump ABCG2 with Different Excipients

    Article • Pharmaceutics, December 2025, MDPI AG

    Professor Marc Le Borgne

  8. From toxic materials to food-grade materials: A major challenge for battery design – A mini review

    Article • De Remediis, October 2025, University of Debrecen/ Debreceni Egyetem

    Professor Marc Le Borgne

  9. How can a cuttlefish avoid running out of fuel?

    Article • De Remediis, September 2025, University of Debrecen/ Debreceni Egyetem

    Professor Marc Le Borgne

  10. Kinetics of benzophenone-3 release from clay minerals or organosilicates for sun protection formulation

    Article • International Journal of Pharmaceutics, September 2025, Elsevier

    Professor Marc Le Borgne

  11. Exploring the biological potential of the brominated indenoindole MC11 and its interaction with protein kinase CK2

    Article • Biological Chemistry, March 2025, De Gruyter

    Professor Marc Le Borgne

  12. Design, synthesis, and structure–activity relationship studies of 6H-benzo[b]indeno[1,2-d]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors

    Article • RSC Medicinal Chemistry, January 2025, Royal Society of Chemistry

    Professor Marc Le Borgne

  13. To be or not to be manipulated by our bacteria?

    Article • De Remediis, December 2024, University of Debrecen/ Debreceni Egyetem

    Professor Marc Le Borgne

  14. Polyphosphoric acid (PPA): a new, highly efficient catalyst for the synthesis of functionalized azepino phthalazine hybrids

    Article • Zeitschrift für Naturforschung B, December 2024, De Gruyter

    Professor Marc Le Borgne

  15. Antibody–drug conjugates: prospects for the next generation

    Article • Drug Discovery Today, December 2024, Elsevier

    Professor Marc Le Borgne

  16. Efficient synthesis, crystallographic study, antimicrobial activity and in silico studies of novel bioactive α-aminophosphonates based on pyridine moiety

    Article • Journal of Molecular Structure, August 2024, Elsevier

    Professor Marc Le Borgne

  17. New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex

    Article • Pharmaceuticals, December 2023, MDPI AG

    Professor Marc Le Borgne

  18. Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients

    Article • Pharmaceutics, November 2023, MDPI AG

    Professor Marc Le Borgne

  19. Drug candidates targeting multidrug resistance in cancer and infections

    Article • European Journal of Medicinal Chemistry, March 2023, Elsevier

    Professor Marc Le Borgne

  20. Inhibitors of ABCG2-mediated multidrug resistance: Lead generation through computer-aided drug design

    Article • European Journal of Medicinal Chemistry, February 2023, Elsevier

    Professor Marc Le Borgne

  21. The Journey towards Solubility Assessment of Small Molecules Using HPLC-DAD

    Article • November 2022, MDPI AG

    Professor Marc Le Borgne

  22. Toxicological Risks of the Cobalt–Chromium Alloys in Dentistry: A Systematic Review

    Article • Materials, August 2022, MDPI AG

    Professor Marc Le Borgne

  23. Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production

    Article • Pharmaceuticals, June 2022, MDPI AG

    Professor Marc Le Borgne

  24. Synthesis, in silico study (DFT, ADMET) and crystal structure of novel sulfamoyloxy-oxazolidinones: Interaction with SARS-CoV-2

    Article • Journal of Molecular Structure, June 2022, Elsevier

    Professor Marc Le Borgne

  25. Improved biological performance of ketoprofen using novel modified halloysite clay nanotubes

    Article • Applied Clay Science, January 2022, Elsevier

    Professor Marc Le Borgne

  26. 4,5,7‐Trisubstituted indeno[1,2‐ b ]indole inhibits CK2 activity in tumor cells equivalent to CX‐4945 and shows strong anti‐migratory effects

    Article • FEBS Open Bio, December 2021, Wiley

    Professor Marc Le Borgne

  27. Biological evaluation of 4,5,7-trisubstituted Indeno[1,2-<em>b</em>]indoles reveals a potent inhibitor of protein kinase CK2 in tumor cells with diverse anti-cancer effects and preferential cytoplasmic localization

    Article • November 2021, MDPI AG

    Professor Marc Le Borgne

  28. Triazole-indole hybrid molecules as antifungal agents: Design, synthesis and biological activity, and beyond

    Article • November 2021, MDPI AG

    Professor Marc Le Borgne

  29. Brain safety concerns of nanomedicines: The need for a specific regulatory framework

    Article • Drug Discovery Today, November 2021, Elsevier

    Professor Marc Le Borgne

  30. Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-b]indole Derivative, Discovered as CK2 Inhibitor

    Article • Pharmaceuticals, June 2021, MDPI AG

    Professor Marc Le Borgne

  31. Adsorption studies of benzophenone-3 onto clay minerals and organosilicates: Kinetics and modelling

    Article • Applied Clay Science, March 2021, Elsevier

    Professor Marc Le Borgne

  32. Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2

    Article • European Journal of Medicinal Chemistry, February 2021, Elsevier

    Professor Marc Le Borgne

  33. Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles

    Article • Scientific Reports, January 2021, Springer Science + Business Media

    Professor Marc Le Borgne

  34. Microwave-accelerated multicomponent synthesis and X-ray characterization of novel benzothiadiazinone dioxide derivatives, analogues of Monastrol

    Article • Research on Chemical Intermediates, January 2021, Springer Science + Business Media

    Professor Marc Le Borgne

  35. Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2021, Taylor & Francis

    Professor Marc Le Borgne

  36. Ninhydrins inhibit carbonic anhydrases directly binding to the metal ion

    Article • European Journal of Medicinal Chemistry, January 2021, Elsevier

    Professor Marc Le Borgne

  37. Cobalt–Chromium Dental Alloys: Metal Exposures, Toxicological Risks, CMR Classification, and EU Regulatory Framework

    Article • Crystals, December 2020, MDPI AG

    Professor Marc Le Borgne

  38. Development of water-soluble ternary system for enhancing biological activities of mefenamic acid

    Article • November 2020, MDPI AG

    Professor Marc Le Borgne

  39. Indeno[1,2-<em>b</em>]indole scaffold in drug discovery: An effective template in kinase inhibitor medicinal chemistry

    Article • November 2020, MDPI AG

    Professor Marc Le Borgne

  40. Isoform specific inhibition of human protein kinase CK2α and CK2α’ by an indenoindole derivative

    Article • November 2020, MDPI AG

    Professor Marc Le Borgne

  41. Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols

    Article • Pharmaceuticals, August 2020, MDPI AG

    Professor Marc Le Borgne

  42. Fragment Linking Strategies for Structure-Based Drug Design

    Article • Journal of Medicinal Chemistry, June 2020, American Chemical Society (ACS)

    Professor Marc Le Borgne

  43. Improved Surface Display of Human Hyal1 and Identification of Testosterone Propionate and Chicoric Acid as New Inhibitors

    Article • Pharmaceuticals, March 2020, MDPI AG

    Professor Marc Le Borgne

  44. Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2020, Taylor & Francis

    Professor Marc Le Borgne

  45. Synthesis of new piperazinyl-pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of Candida albicans multidrug transporters by a Buchwald–Hartwig cross-coupling reaction

    Article • RSC Advances, January 2020, Royal Society of Chemistry

    Professor Marc Le Borgne

  46. QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor

    Article • Molecules, December 2019, MDPI AG

    Professor Marc Le Borgne

  47. Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors

    Article • Scientific Reports, November 2019, Springer Science + Business Media

    Professor Marc Le Borgne

  48. Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures

    Article • ACS Omega, March 2019, American Chemical Society (ACS)

    Professor Marc Le Borgne

  49. A comparative adsorption study of benzophenone-3 onto synthesized lipophilic organosilicate, Laponite and montmorillonite

    Article • Applied Clay Science, March 2019, Elsevier

    Professor Marc Le Borgne

  50. Synthesis and biological evaluation of new dipicolylamine zinc chelators as metallo-β-lactamase inhibitors

    Article • Tetrahedron, March 2019, Elsevier

    Professor Marc Le Borgne

  51. 2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. Part 2: Structure–based optimization and investigation of effects specific to the allosteric mode of action

    Article • Journal of Medicinal Chemistry, January 2019, American Chemical Society (ACS)

    Professor Marc Le Borgne

  52. 2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. Part 1: Identification of an allosteric binding site

    Article • Journal of Medicinal Chemistry, January 2019, American Chemical Society (ACS)

    Professor Marc Le Borgne

  53. Behaviour of Tetrabenazine in Acid Medium: Reassessment and Impact on Formulation

    Article • Pharmaceutics, January 2019, MDPI AG

    Professor Marc Le Borgne

  54. In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2019, Taylor & Francis

    Professor Marc Le Borgne

  55. 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2019, Taylor & Francis

    Professor Marc Le Borgne

  56. Carbazole scaffolds in cancer therapy: a review from 2012 to 2018

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2019, Taylor & Francis

    Professor Marc Le Borgne

  57. Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors

    Article • MedChemComm, January 2019, Royal Society of Chemistry

    Professor Marc Le Borgne

  58. Comparison of SEC and AF4 analytical tools for size estimation of typhoid Vi polysaccharides

    Article • Analytical Methods, January 2019, Royal Society of Chemistry

    Professor Marc Le Borgne

  59. Synthesis and preclinical evaluation of TPA-based zinc chelators as metallo-β-lactamase inhibitors

    Article • ACS Infectious Diseases, July 2018, American Chemical Society (ACS)

    Professor Marc Le Borgne

  60. Synthesis, Spectroscopic Characterization, and In Vitro Antibacterial Evaluation of Novel Functionalized Sulfamidocarbonyloxyphosphonates

    Article • Molecules, July 2018, MDPI AG

    Professor Marc Le Borgne

  61. Structure-based design and profiling of novel 17β-HSD14 inhibitors

    Article • European Journal of Medicinal Chemistry, July 2018, Elsevier

    Professor Marc Le Borgne

  62. Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7

    Article • Pharmaceuticals, January 2018, MDPI AG

    Professor Marc Le Borgne

  63. Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2018, Taylor & Francis

    Professor Luciano Saso, Professor Marc Le Borgne, Prof. Grzegorz Wegrzyn

  64. Enhancement of iodinin solubility by encapsulation into cyclodextrin nanoparticles

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2018, Taylor & Francis

    Professor Marc Le Borgne

  65. Synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2018, Taylor & Francis

    Professor Marc Le Borgne, Pr. ABDELMALEK BOURAIOU, Bachir Zouchoune

  66. LCCDD: Linker chemistry at the crossroads of drug designing

    Article • Drug Designing Open Access, January 2018, OMICS Publishing Group

    Professor Marc Le Borgne

  67. 25th Conference of GP2A

    Article • Pharmaceuticals, December 2017, MDPI AG

    Professor Marc Le Borgne

  68. Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α′

    Article • Pharmaceuticals, December 2017, MDPI AG

    Professor Marc Le Borgne

  69. The combined use of analytical tools for exploring tetanus toxin and tetanus toxoid structures

    Article • Journal of Chromatography B, June 2017, Elsevier

    Professor Marc Le Borgne

  70. Sleep Disorders and Therapeutic Management: A Survey in a French Population of Prisoners

    Article • Journal of Correctional Health Care, March 2017, SAGE Publications

    Professor Marc Le Borgne

  71. An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2

    Article • Pharmaceuticals, March 2017, MDPI AG

    Professor Marc Le Borgne

  72. Sequential MCR/Fisher indolization strategy for the construction of polycyclic carbazole derivatives

    Article • Tetrahedron Letters, March 2017, Elsevier

    Professor Marc Le Borgne, Pr. ABDELMALEK BOURAIOU

  73. In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface

    Article • Pharmaceuticals, February 2017, MDPI AG

    Professor Marc Le Borgne

  74. Second International Electronic Conference on Medicinal Chemistry (ECMC-2)

    Article • Pharmaceuticals, January 2017, MDPI AG

    Professor Marc Le Borgne, Dr Jean Jacques Vanden Eynde

  75. Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining

    Article • Pharmaceuticals, January 2017, MDPI AG

    Professor Marc Le Borgne

  76. DMAP as a new efficient catalyst for the one-pot synthesis of condensed phthalazines

    Article • Zeitschrift für Naturforschung B, January 2017, De Gruyter

    Professor Marc Le Borgne, Pr. ABDELMALEK BOURAIOU

  77. First effective inhibitors of ABCC2

    Article • European Journal of Medicinal Chemistry, October 2016, Elsevier

    Professor Marc Le Borgne

  78. MALDI-MS screening of indenoindoles

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, June 2016, Taylor & Francis

    Professor Marc Le Borgne

  79. Toward selective CK2alpha and CK2alpha’ inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha’

    Article • Journal of Pharmaceutical and Biomedical Analysis, March 2016, Elsevier

    Professor Marc Le Borgne

  80. An innovative method for the extraction and quantification of curcuminoids from a complex matrix

    Article • Chemical Sciences Journal, January 2016, OMICS Publishing Group

    Professor Marc Le Borgne

  81. Candidate Molecule Selection Based on In Silico Predicted ADMET Properties of 12 Indenoindole Derivatives

    Article • Chemical Informatics, January 2016, Scitechnol Biosoft Pvt. Ltd.

    Professor Marc Le Borgne

  82. Conformational and dynamic considerations in drug design for G-protein coupled receptors

    Article • Medicinal Chemistry, January 2016, OMICS Publishing Group

    Professor Marc Le Borgne

  83. 1st Joint European Conference on Therapeutic Targets and Medicinal Chemistry (TTMC 2015)

    Article • Pharmaceuticals, December 2015, MDPI AG

    Professor Marc Le Borgne

  84. Crystal structure of 13-phenyl-2,3,4,13-tetrahydro-1H-indazolo[1,2-b]phthalazine-1,6,11-trione

    Article • Acta Crystallographica Section E Crystallographic Communications, December 2015, International Union of Crystallography

    Professor Marc Le Borgne, Pr. ABDELMALEK BOURAIOU

  85. Advances in peptidomimetics as inhibitors of ABC transporters

    Article • November 2015, MDPI AG

    Professor Marc Le Borgne

  86. ChemInform Abstract: A One-Pot Three-Component Synthesis of Novel α-Sulfamidophosphonates under Ultrasound Irradiation and Catalyst-Free Conditions.

    Article • ChemInform, August 2015, Wiley

    Professor Marc Le Borgne

  87. ChemInform Abstract: Microwave-Assisted Oxidation of Indan-1-ones into Ninhydrins.

    Article • ChemInform, July 2015, Wiley

    Professor Marc Le Borgne

  88. Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity

    Article • Drug Design Development and Therapy, July 2015, Taylor & Francis

    Professor Marc Le Borgne, Dr Glaucio Valdameri

  89. Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2

    Article • Pharmaceuticals, June 2015, MDPI AG

    Professor Marc Le Borgne

  90. Functional display of heterotetrameric human protein kinase CK2 on Escherichia coli: a novel tool for drug discovery

    Article • Microbial Cell Factories, June 2015, Springer Science + Business Media

    Professor Marc Le Borgne

  91. Microwave-assisted oxidation of indan-1-ones into ninhydrins

    Article • Tetrahedron Letters, April 2015, Elsevier

    Professor Marc Le Borgne

  92. Synthesis of New Steroidal Inhibitors of P-Glycoprotein-Mediated Multidrug Resistance and Biological Evaluation on K562/R7 Erythroleukemia Cells

    Article • Journal of Medicinal Chemistry, February 2015, American Chemical Society (ACS)

    Professor Marc Le Borgne

  93. From Protein Kinase CK2 to ABCG2 activities

    Article • Journal of Medicinal Chemistry, January 2015, American Chemical Society (ACS)

    Professor Marc Le Borgne

  94. A one-pot three-component synthesis of novel α-sulfamidophosphonates under ultrasound irradiation and catalyst-free conditions

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Professor MALIKA BERREDJEM, Professor Marc Le Borgne

  95. Biomimetic synthesis of Tramadol

    Article • Chemical Communications, January 2015, Royal Society of Chemistry

    Professor Marc Le Borgne

  96. Mechanisms of depolymerization and activation of a polysialic acid and its tetramer by hydrogen peroxide

    Article • Carbohydrate Polymers, January 2015, Elsevier

    Professor Marc Le Borgne

  97. Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells

    Article • Bioorganic & Medicinal Chemistry Letters, August 2014, Elsevier

    Professor Marc Le Borgne

  98. Carbazoles derivatives

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, April 2014, Taylor & Francis

    Professor Marc Le Borgne

  99. Structural elucidation of two photolytic degradation products of tetrabenazine

    Article • Journal of Pharmaceutical and Biomedical Analysis, March 2014, Elsevier

    Professor Marc Le Borgne

  100. Oxidation of sialic acid using hydrogen peroxide as a new method to tune the reducing activity

    Article • Carbohydrate Research, March 2014, Elsevier

    Professor Marc Le Borgne

  101. ChemInform Abstract: Indenoindoles and Cyclopentacarbazoles as Bioactive Compounds: Synthesis and Biological Applications

    Article • ChemInform, January 2014, Wiley

    Professor Marc Le Borgne

  102. Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors

    Article • ChemMedChem, November 2013, Wiley

    Professor Marc Le Borgne

  103. Indenoindoles and cyclopentacarbazoles as bioactive compounds: Synthesis and biological applications

    Article • European Journal of Medicinal Chemistry, November 2013, Elsevier

    Professor Marc Le Borgne

  104. 1H and13C NMR assignments of bioactive indeno[1,2-b]indole-10-one derivatives

    Article • Magnetic Resonance in Chemistry, October 2013, Wiley

    Professor Marc Le Borgne

  105. Natural products: African tree gets to the root of pain

    Article • Nature, September 2013, Nature

    Professor Marc Le Borgne

  106. Occurrence of the Synthetic Analgesic Tramadol in an African Medicinal Plant

    Article • Angewandte Chemie, September 2013, Wiley

    Professor Marc Le Borgne

  107. Occurrence of the Synthetic Analgesic Tramadol in an African Medicinal Plant

    Article • Angewandte Chemie, September 2013, Wiley

    Professor Marc Le Borgne

  108. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2

    Article • European Journal of Medicinal Chemistry, July 2013, Elsevier

    Professor Marc Le Borgne

  109. A safe and practical method for the preparation of 7α-thioether and thioester derivatives of spironolactone

    Article • Steroids, January 2013, Elsevier

    Professor Marc Le Borgne

  110. Preparation and characterization of CK2 inhibitor-loaded cyclodextrin nanoparticles for drug delivery

    Article • International Journal of Pharmaceutics, January 2013, Elsevier

    Professor Marc Le Borgne

  111. Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines

    Article • Biochemical and Biophysical Research Communications, July 2012, Elsevier

    Professor Marc Le Borgne

  112. Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors

    Article • Bioorganic & Medicinal Chemistry, April 2012, Elsevier

    Professor Marc Le Borgne

  113. Design, Synthesis, and in vitro Antifungal Activity of 1-[(4-Substituted-benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols

    Article • ChemMedChem, March 2011, Wiley

    Professor Marc Le Borgne

  114. ChemInform Abstract: Synthesis and in vitro Evaluation of 3-(1-Azolylmethyl)-1H-indoles and 3-(1-Azolyl-1-phenylmethyl)-1H-indoles as Inhibitors of P450 Arom.

    Article • ChemInform, August 2010, Wiley

    Professor Marc Le Borgne

  115. ChemInform Abstract: New Selective Nonsteroidal Aromatase Inhibitors: Synthesis and Inhibitory Activity of 2, 3, or 5-(α-Azolylbenzyl)-1H-indoles.

    Article • ChemInform, June 2010, Wiley

    Professor Marc Le Borgne

  116. Proceedings of the 17th annual conference of the Groupement des Pharmacochimistes de l’Arc Atlantique (GP2A) and the 22nd “Journées Franco-Belges de Pharmacochimie”

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, March 2010, Taylor & Francis

    Professor Marc Le Borgne

  117. 81: Targeting casein kinase 2 in drug discovery: identification of new chemical entities

    Article • Bulletin du Cancer, March 2010, Elsevier

    Professor Marc Le Borgne

  118. Échappement Tumoral

    Article • Bulletin du Cancer, March 2010, Elsevier

    Professor Marc Le Borgne

  119. Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols

    Article • Bioorganic & Medicinal Chemistry Letters, October 2009, Elsevier

    Professor Marc Le Borgne

  120. Design, synthesis and evaluation of 3-(imidazol- 1-ylmethyl)indoles as antileishmanial agents. Part II

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, March 2009, Taylor & Francis

    Professor Marc Le Borgne

  121. Synthesis and structure–activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents

    Article • Bioorganic & Medicinal Chemistry Letters, January 2009, Elsevier

    Professor Marc Le Borgne

  122. Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, August 2008, Elsevier

    Professor Marc Le Borgne

  123. Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents

    Article • Bioorganic & Medicinal Chemistry Letters, March 2008, Elsevier

    Professor Marc Le Borgne

  124. Proceedings of the 16th annual conference of the Groupement des Pharmacochimistes de l'Arc Atlantique (GP2A)

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2008, Taylor & Francis

    Professor Marc Le Borgne

  125. Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety

    Article • Bioorganic & Medicinal Chemistry Letters, July 2007, Elsevier

    Professor Marc Le Borgne

  126. P1674 Broad spectrum anti-Candida activities of a new indolyl-triazole, NL114

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Marc Le Borgne

  127. P1678 New antiprotozoal drugs refered as antimicrotubular haloacetamidobenzoates

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Marc Le Borgne

  128. Editorial

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2007, Taylor & Francis

    Professor Marc Le Borgne

  129. Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(α-azolylbenzyl)-1H-indoles as selective aromatase inhibitors

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2007, Taylor & Francis

    Professor Marc Le Borgne

  130. Efficient Microwave-Assisted Synthesis of 1-(1H-Indol-1-yl)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as Antifungal Agents.

    Article • ChemInform, December 2006, Wiley

    Professor Marc Le Borgne

  131. Efficient microwave-assisted synthesis of 1-(1H-indol-1-yl)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents

    Article • Tetrahedron Letters, September 2006, Elsevier

    Professor Marc Le Borgne

  132. A 3D-QSAR CoMSIA study on 3-azolylmethylindoles as anti-leishmanial agents

    Article • SAR and QSAR in Environmental Research, June 2006, Taylor & Francis

    Professor Marc Le Borgne

  133. Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, March 2006, Elsevier

    Professor Marc Le Borgne

  134. Antileishmanial activities and mechanisms of action of indole-based azoles

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2006, Taylor & Francis

    Professor Marc Le Borgne

  135. Proceedings of the 14thAnnual Conference on the Grouping of Pharmacochemistry of the Atlantic Arc (GP2A)

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2006, Taylor & Francis

    Professor Marc Le Borgne

  136. Three-dimensional model of cytochrome P450 human aromatase

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2005, Taylor & Francis

    Professor Marc Le Borgne

  137. Proceedings of the 13th Annual Conference on the Grouping of Pharmacochemistry of the Atlantic Arc (GP2A)

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2005, Taylor & Francis

    Professor Marc Le Borgne

  138. 12th European Conference of GP2A—La Rochelle 2003

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, December 2004, Taylor & Francis

    Professor Marc Le Borgne

  139. Synthesis and Antileishmanial Activity of 3-Imidazolylalkylindoles. Part I

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, December 2004, Taylor & Francis

    Professor Marc Le Borgne

  140. 2- and 3-[(Aryl)(azolyl)methyl]indoles as Potential Non-steroidal Aromatase Inhibitors

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, December 2004, Taylor & Francis

    Professor Marc Le Borgne

  141. Abstracts of the Congress '18emes Journees Franco-Belges de Pharmacochimie' - LUXEMBOURG

    Article • Fundamental and Clinical Pharmacology, October 2004, Wiley

    Professor Marc Le Borgne

  142. Preparation and Pharmacological Profile of 7-(α-Azolylbenzyl)-1H-indoles and Indolines as New Aromatase Inhibitors.

    Article • ChemInform, July 2003, Wiley

    Professor Marc Le Borgne

  143. Synthesis and Antifungal Activity of New 1-Halogenobenzyl-3-imidazolylmethylindole Derivatives.

    Article • ChemInform, July 2003, Wiley

    Professor Marc Le Borgne

  144. Preparation and pharmacological profile of 7-(α-Azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, May 2003, Elsevier

    Professor Marc Le Borgne

  145. Retinoic Acid Metabolism Inhibition by 3-Azolylmethyl-1H-indoles and 2, 3 or 5-(α-Azolylbenzyl)-1H-indoles

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, April 2003, Taylor & Francis

    Professor Marc Le Borgne

  146. Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives

    Article • European Journal of Medicinal Chemistry, January 2003, Elsevier

    Professor Marc Le Borgne

  147. Synthesis and Antileishmanial Activity of 3-(α-Azolylbenzyl)indoles

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2002, Taylor & Francis

    Professor Marc Le Borgne

  148. In Vitro Activity of a New Antifungal Azolyl-substituted Indole Against Aspergillus fumigatus

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2002, Taylor & Francis

    Professor Marc Le Borgne

  149. Potential application of plant lipid transfer proteins for drug delivery

    Article • Biochemical Pharmacology, September 2001, Elsevier

    Professor Marc Le Borgne

  150. ChemInform Abstract: Synthesis and Biological Evaluation of Indole Derivatives Acting as Antiinflammatory or Antitumoral Drugs

    Article • ChemInform, March 2001, Wiley

    Professor Marc Le Borgne

  151. New selective nonsteroidal aromatase inhibitors: Synthesis and inhibitory activity of 2,3 or 5-(α-azolylbenzyl)-1H-indoles

    Article • Bioorganic & Medicinal Chemistry Letters, February 1999, Elsevier

    Professor Marc Le Borgne

  152. Synthesis andIn Vitro Evaluation of 3-(1-Azolylmethyl)-1H-indoles and 3-(1-Azolyl-1-phenylmethyl)-1H-indoles as Inhibitors of P450 arom

    Article • Archiv der Pharmazie, January 1997, Wiley

    Professor Marc Le Borgne